Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test

Brain Research Bulletin

Volumn 67, Issue 1-2, 2005, Pages 53-61

  Kaster, Manuella P ^a   Santos, Adair R S ^a   Rodrigues, Ana L S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Adenosine; Behavioural despair; Depression; Serotonergic system

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ANTIDEPRESSANT AGENT; FENCLONINE; FLUOXETINE; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SWIMMING; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; FEMALE; MALE; MICE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; SWIMMING; SYNAPTIC TRANSMISSION;

EID: 24044516223     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2005.05.025     Document Type: Article

References (53)

1. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Neuropharmacology 45 2003 1050 1056
2. 1A receptor agonist properties of pindolol in combination with citalopram on serotoninergic dorsal raphe cell firing in vivo Psychopharmacology 151 2000 77 84
3. F. Artigas Pindolol, 5-hydroxytryptamine, and antidepressant augmentation Arch. Gen. Psychiatry 52 1995 969 971
4. 1A antagonists Trends Neurosci. 19 1996 378 383
5. 1A agonists in the treatment of depression? Biol. Psychiatry 53 2003 193 203
6. F. Borsini, and A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94 1988 147 160
7. F. Borsini Role of the serotonergic system in the forced swimming test Neurosci. Biobehav. Rev. 19 1995 377 395
8. 2A receptors in depression J. Psychiatry Neurosci. 29 2004 252 265
9. 1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats Neuropharmacology 30 1991 711 717
10. 1A autoreceptors in vivo Br. J. Pharmacol. 124 1998 206 212
11. R.A. Cunha Adenosine as a neuromodulador and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochem. Int. 38 2001 107 125
12. M.A. Da Rocha, A.J. Puech, and M.H. Thiebot Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice J. Psychopharmacol. 11 1997 211 218
13. 1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex Eur. J. Pharmacol. 345 1998 41 46
14. 2 receptors, depression and anxiety Pharmacol. Biochem. Behav. 29 1988 819 820
15. 1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat Eur. Neuropsychopharmacol. 14 2004 487 495
16. 2 receptors: microdialysis studies in the awake and anaesthetized rat Neuropharmacology 33 1994 411 421
17. A.L. Eckeli, F. Dach, and A.L.S. Rodrigues Acute treatments with GMP produce antidepressant-like effects in mice Neuroreport 11 2000 1839 1843
18. A.S. Elhwuegi Central monoamines and their role in major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 435 451
19. 1 receptors modulate anxiety in CD1 mice Psychopharmacology 136 1998 311 319
20. E.C. Gavioli, C.W. Vaughan, G. Marzola, R. Guerrini, V.A. Mitchell, S. Zucchini, T.C.M. de Lima, G.A. Rae, S. Salvadori, D. Regoli, and G. Calo Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice Naunyn-Schmiedeberg's Arch. Pharmacol. 369 2004 547 553
21. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) Eur. J. Pharmacol. 154 1988 339 341
22. 1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro Eur. J. Pharmacol. 211 1992 211 219
23. 1A receptors-G protein interactions in brain following chronic antidepressant administration Neuropsychopharmacology 26 2002 565 573
24. 1A receptors: behavioural and in vivo brain microdialysis studies Life Sci. 46 1990 955 963
25. S. Hjorth, H.J. Bengtsson, A. Kullberg, D. Carlzon, H. Peilot, and S.B. Auerbach Serotonin autoreceptor function and antidepressant drug action J. Psychopharmacol. 14 2000 177 185
26. 1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone Eur. J. Pharmacol. 510 2005 49 57
27. 2A receptors Neurosci. Lett. 355 2004 21 24
28. 1A receptor agonists on operant responding under a response duration differentiation schedule Behav. Pharmacol. 9 1998 309 318
29. 2A receptor Nature 388 1997 674 678
30. C. Lopez-Rubalcava, and I. Lucki Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test Neuropsychopharmacology 22 2000 191 199
31. 1A receptors Br. J. Pharmacol. 108 1993 669 677
32. A. Mendonça, A.M. Sebastião, and J.A. Ribeiro Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33 2000 258 274
33. M.J. Millan, M. Brocco, S. Veiga, L. Cistarelli, C. Melon, and A. Gobert WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex Eur. J. Pharmacol. 341 1998 165 167
34. 1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats Eur. J. Pharmacol. 372 1999 127 134
35. 1B receptors in the mediation of behavior in the forced swim test in mice Neuropsychopharmacology 24 2001 391 398
36. M.E. Page, M.J. Detke, A. Dalvi, L.G. Kirby, and I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology 147 1992 162 167
37. P. Plenge, and E.T. Mellerup Pindolol and the acceleration of the antidepressant response J. Affect. Disord. 75 2003 285 289
38. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Ther. 229 1977 327 336
39. E. Przegalinski, A.M. Ismaiel, E. Chojnacka-Wojcik, B. Budziszewska, E. Tatarczynska, and E. Blaszczynska The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)-tetralin, is antagonized by NAN-190 in rat Neuropharmacology 29 1990 521 526
40. E. Przegalinski, E. Tatarczynska, and E. Chojnacka-Wojcik The role of hippocampal 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists Neuropharmacology 34 1995 1211 1217
41. 1B receptors in antidepressant drug actions in the mouse forced swimming test Eur. J. Pharmacol. 318 1996 213 220
42. 3 receptors in the activity of antidepressants in the mouse forced swimming test Eur. J. Pharmacol. 325 1997 129 135
43. J.P. Redrobe, M. Bourin, M.C. Colombel, and G.B. Baker Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity Psychopharmacology 138 1998 1 8
44. J.P. Redrobe, M. Bourin, M.C. Colombel, and G.B. Baker Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms J. Psychopharmacol. 12 1998 348 355
45. J.A. Ribeiro, A.M. Sebastião, and A. Mendonça Adenosine receptors in the nervous system: pathophysiological implications Prog. Neurobiol. 68 2003 377 392
46. S.C. Risch, and C.B. Nemeroff Neurochemical alterations of serotonergic neuronal systems in depression J. Clin. Psychiatry 53 1992 3 7
47. M.O. Rojas-Corrales, J. Gibert-Rahola, and J.A. Micó Tramadol induces antidepressant-type effects in mice Life Sci. 63 1998 175 180
48. A.O. Rosa, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav. Brain Res. 144 2003 87 93
49. 11C]WAY-100635: effects of depression and antidepressant treatment Arch. Gen. Psychiatry 57 2000 174 180
50. 1A receptors Neuropharmacology 324 1993 331 340
51. P. Willner The validity of animal models for depression Psychopharmacology 83 1984 1 16
52. A.D.E. Zomkowski, L. Hammes, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Agmatine produces antidepressant-like effects in two models of depression in mice Neuroreport 13 2002 387 391
53. A.D.E. Zomkowski, A.O. Rosa, J. Lin, A.R.S. Santos, J.B. Calixto, and A.L.S. Rodrigues Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test Brain Res. 1023 2004 253 263